LCM
MBOT icon

Lazari Capital Management’s Microbot Medical MBOT Stock Holding History

Lazari Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.4K Buy
36,600
+13,345
+57% +$27.2K 0.02% 181
2026
Q1 		$56K Buy
23,255
+2,000
+9% +$4.47K 0.02% 170
2025
Q4 		$42.5K Hold
21,255
– – 0.01% 162
2025
Q3 		$64.8K Hold
21,255
– – 0.02% 160
2025
Q2 		$53.6K Buy
+21,255
New +$50.9K 0.02% 152

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Lazari Capital Management's MBOT Position: Q2 2026 in Review

Lazari Capital Management increased its Microbot Medical (MBOT) stake by 57% in Q2 2026, buying an estimated $27.2K and bringing the position to 36,600 shares worth $71.4K. The position accounts for 0.02% of the portfolio, ranked #181.

Lazari Capital Management first reported a position in MBOT in Q2 2025 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Lazari Capital Management held 36,600 shares of Microbot Medical worth $71.4K as of Q2 2026.
  • Lazari Capital Management bought 13,345 Microbot Medical shares in Q2 2026, an estimated $27.2K.
  • Microbot Medical made up 0.02% of Lazari Capital Management's portfolio in Q2 2026, its #181 holding.
  • Lazari Capital Management first reported a position in Microbot Medical in Q2 2025 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.